Home
Browse
Prime browse
Clustered VIS browse
Search
Curation
Gene
Target gene
All
Oncogene
Tumor suppressor gene
Nearby gene
All
Oncogene
Tumor suppressor gene
MicroRNA
RNA-interaction
ncRNA
Host2Host
Host2Virus
Virus2Host
• miRNA
Host2Host
Host2Virus
Virus2Host
• lncRNA
Host2Host
Host2Virus
Virus2Host
Download
Statistics
Help
VISDB
Viral Integration Site DataBase
Homepage
Prime VIS Browse Options
TVIS30000250
Basic Information
VIS ID
TVIS30000250
Fusion event
HIV-NFIX integration
Validated
No
Detection method
NG-SGS
Data source
download(RID)
Sample type
PBMC
Disease
HIV-infected disease (HID)
Quality evaluation
Normal
Reported year
2018
PubMed ID
30024859
Virus Sequence
Virus name
HIV
Reference genome
K03455.1
Host Sequence
Chromosome
chr19
Cytoband
p13.13
Reference genome
GRCh37/hg19
Start
13196940/13086126 (Hg38)
End
13196940/13086126 (Hg38)
Orient
-
Location type
Intronic
Fragile sites / regions
FRA19B
Target gene
NFIX
miRNAs that regulate target gene
hsa-mir-223-3p
;
hsa-mir-124-3p
;
hsa-mir-324-5p
;
hsa-mir-149-5p
;
hsa-mir-506-3p
;
hsa-mir-765
;
hsa-mir-4459
;
hsa-mir-5582-5p
;
hsa-mir-6748-5p
;
hsa-mir-6742-5p
;
hsa-mir-6769b-5p
;
hsa-mir-6769a-5p
;
hsa-mir-92a-2-5p
;
hsa-mir-4483
;
hsa-mir-1293
;
hsa-mir-6756-5p
;
hsa-mir-6766-5p
;
hsa-mir-6745
;
hsa-mir-363-5p
;
hsa-mir-6885-5p
;
hsa-mir-328-5p
;
hsa-mir-4697-5p
;
hsa-mir-4488
;
hsa-mir-1237-5p
;
hsa-mir-6883-5p
;
hsa-mir-6785-5p
;
hsa-mir-4728-5p
;
hsa-mir-6789-3p
;
hsa-mir-149-3p
;
hsa-mir-6804-5p
;
hsa-mir-7150
;
hsa-mir-6797-5p
;
hsa-mir-1249-5p
;
hsa-mir-6133
;
hsa-mir-6129
;
hsa-mir-6130
;
hsa-mir-6127
;
hsa-mir-4510
;
hsa-mir-4419a
;
hsa-mir-212-5p
;
hsa-mir-4756-5p
;
hsa-mir-1321
;
hsa-mir-4739
;
hsa-mir-3910
;
hsa-mir-3714
;
hsa-mir-128-2-5p
;
hsa-mir-128-1-5p
;
hsa-mir-3144-5p
;
hsa-mir-6781-5p
;
hsa-mir-744-5p
;
hsa-mir-4749-5p
;
hsa-mir-4706
;
hsa-mir-3648
;
hsa-mir-6869-3p
;
hsa-mir-6846-3p
;
hsa-mir-4734
;
hsa-mir-6752-3p
;
hsa-mir-6810-3p
;
hsa-mir-6801-3p
;
hsa-mir-6825-5p
;
hsa-mir-3184-5p
;
hsa-mir-423-5p
;
hsa-mir-6809-3p
;
hsa-mir-6833-3p
;
hsa-mir-4768-5p
;
hsa-mir-6873-3p
;
hsa-mir-6845-3p
;
hsa-mir-1199-5p
;
hsa-mir-1275
;
hsa-mir-139-3p
;
hsa-mir-24-1-5p
;
hsa-mir-24-2-5p
;
hsa-mir-25-5p
;
hsa-mir-3064-5p
;
hsa-mir-3141
;
hsa-mir-3202
;
hsa-mir-4294
;
hsa-mir-4303
;
hsa-mir-4492
;
hsa-mir-4498
;
hsa-mir-4525
;
hsa-mir-4665-5p
;
hsa-mir-4722-5p
;
hsa-mir-4747-5p
;
hsa-mir-483-5p
;
hsa-mir-5001-5p
;
hsa-mir-5010-5p
;
hsa-mir-516b-5p
;
hsa-mir-5196-5p
;
hsa-mir-541-3p
;
hsa-mir-5580-5p
;
hsa-mir-604
;
hsa-mir-625-5p
;
hsa-mir-647
;
hsa-mir-6504-5p
;
hsa-mir-6515-5p
;
hsa-mir-654-5p
;
hsa-mir-6746-5p
;
hsa-mir-6751-3p
;
hsa-mir-6758-5p
;
hsa-mir-6762-3p
;
hsa-mir-6807-5p
;
hsa-mir-6856-5p
;
hsa-mir-6882-3p
;
hsa-mir-762
;
hsa-mir-941
;
hsa-mir-9500
;
hsa-let-7a-2-3p
;
hsa-let-7g-3p
;
hsa-mir-1179
;
hsa-mir-1288-3p
;
hsa-mir-155-3p
;
hsa-mir-1914-3p
;
hsa-mir-296-5p
;
hsa-mir-3169
;
hsa-mir-3685
;
hsa-mir-384
;
hsa-mir-3918
;
hsa-mir-4685-5p
;
hsa-mir-4788
;
hsa-mir-4797-5p
;
hsa-mir-5194
;
hsa-mir-6089
;
hsa-mir-615-5p
;
hsa-mir-6738-5p
;
hsa-mir-6761-3p
;
hsa-mir-6837-5p
;
hsa-mir-6840-3p
;
hsa-mir-7113-5p
;
hsa-mir-7160-3p
;
hsa-mir-874-5p
Nearest miRNA
hsa-mir-10395/Upstream/145586; hsa-let-7e/Downstream/750161;
Nearest TSS
ENST00000633603/Upstream/14752;
ENST00000591837/Downstream/16598;
Nearest CpG islands
None/Target,
chr19-CpG: 112/Upstream/60771
,
chr19-CpG: 26/Downstream/1759
Upstream sequence
TGGTCCCCACAGAGGGGACAGCGTTTTTTGAGCAGGTCTTGAAGGGTGTgggaaatagtctttcatacagagagcttcgcagcaagccagcgtgcagtcc
Downstream sequence
tgcctgctcggcctgtgttccggaaaccccagtcagtttggaatgggaagtgcagaggggcggtaggggctggaccagtagaggcatccgtgggggcctt
Reference
Sharaf, R., et al.HIV-1 proviral landscapes distinguish posttreatment controllers from noncontrollers. J Clin Invest,2018,128(9): 4074-4085.
Sample Information
×
Sample name
1C16
Sample type
PBMC
Age
41
Gender
Male
CpG Island Information
×
Download
Curate